Skip to main content
. 2017 Mar 7;8(45):79111–79125. doi: 10.18632/oncotarget.15978

Figure 3. Distribution of pre- and post operative patients with PRL ≥ 200 ng/mL.

Figure 3

Data were tested by Chi-square test at baseline and Fisher’s exact test for other time points.